Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Academic Radiology|July 16, 2008
Development of variable pitch factor scanning for multislice computed tomographyTatsuro Suzuki, Takamasa Ota, Tatsuo Maeda, et al.
Arerugi = [Allergy]|July 13, 2022
[A CHILD CASE OF DIFFUSE CUTANEOUS MASTOCYTOSIS]Yu Hoshino, Kaoruko Yoshida, Takafumi Numata, et al.
The Journal of Dermatology|August 19, 2021
Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single centerMiho Mori, Rie Tobita, Chizu Egusa, et al.
The Journal of Dermatology|October 26, 2024
First reported case of thymoma-associated multiorgan autoimmunity induced by COVID-19Rie Hyobu, Miho Mori, Tatsuo Maeda, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2025
Development of a T cell engaging bispecific antibody targeting long non-coding RNA PVT1Hirotaka Kato, Tomohide Tsukahara, Kenji Murata, et al.
Plos One|April 22, 2014
A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tensionHiroshi Saga, Akira Ohhata, Akio Hayashi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 7, 2014
Inhibition of autotaxin delays breast tumor growth and lung metastasis in miceMatthew G K Benesch, Xiaoyun Tang, Tatsuo Maeda, et al.
The Journal of Investigative Dermatology|July 9, 2016
Identification of an S100A8 Receptor Neuroplastin-β and its Heterodimer Formation with EMMPRINMasakiyo Sakaguchi, Mami Yamamoto, Masashi Miyai, et al.
The Journal of Dermatology|July 24, 2025
Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Extramammary Paget Disease 2025Shigeto Matsushita, Ikko Kajihara, Keita Tsutsui, et al.
Journal of Medicinal Chemistry|November 10, 2017
Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P<sub>1</sub> and S1P<sub>5</sub> Selective Agonist for the Treatment of Autoimmune DiseasesHaruto Kurata, Kensuke Kusumi, Kazuhiro Otsuki, et al.
Pageof 4